Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 28 | 23 | −5 |
| Shares | 2.94M | 2.77M | −171.6K (−5.8%) |
| Value | $8.36M | $7.43M | −$932.0K (−11.1%) |
New holders (1)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 12,021 | $32.0K | 0.00% |
Sold out (6)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Ariel Investments, LLC | 12,033 | $34.0K |
| Arrowstreet Capital, Limited Partnership | 10,700 | $30.0K |
| California Public Employees Retirement System | 10,205 | $29.0K |
| Advisor Group Holdings, Inc. | 730 | $2.00K |
| FMR LLC | 422 | $1.00K |
| Panagora Asset Management Inc | 443 | $1.00K |